7 Recruiting Studies Using Oral Azacitidine
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Oral Azacitidine
🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Best Supportive Care as Maintenance Therapy in Japanese Participants With Acute Myeloid Leukemia (AML) in Complete Remission
📍 Local Institution - 0011 — Huntsville, Alabama
Acute Myeloid Leukemia
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 / Phase3 💊 Investigational Drug / Biologic
Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma
📍 Banner University Medical Center - Tucson — Tucson, Arizona
Ann Arbor Stage III Diffuse Large B-Cell Lymphoma
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 / Phase3 💊 Investigational Drug / Biologic
A Study to Compare the Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care (BSC) Versus Placebo Plus BSC in Participants With International Prognostic Scoring System Revised (IPSS-R) Low- or Intermediate-risk Myelodysplastic Syndrome (MDS)
📍 Local Institution - 0137 — Miami, Florida
Myelodysplastic Syndromes
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
T-Cell Large Granular Lymphocyte Leukemia
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
CC-486 and Nivolumab for the Treatment of Hodgkin Lymphoma Refractory to PD-1 Therapy or Relapsed
📍 City of Hope Medical Center — Duarte, California
Recurrent Classic Hodgkin Lymphoma
View Study & Checklist ➔ 🟢 Recruiting Phase4 💊 Investigational Drug / Biologic
Oral Azacitidine in Transplant-Eligible Patients With Acute Myeloid Leukemia (AML) Suffering From Health-Inequality
📍 Virginia Commonwealth University — Richmond, Virginia
Acute Myeloid Leukemia
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
📍 University of Arkansas for Medical Sciences — Little Rock, Arkansas
Angioimmunoblastic T-cell Lymphoma
View Study & Checklist ➔